Leukemia News and Research

RSS

Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.

Imatinib mesylate (Gleevec) inhibits important pathways that spur cancer growth

A new clinical study has shown that imatinib mesylate (Gleevec) has activity in AIDS-related Kaposi's sarcoma (KS). Imatinib inhibits important pathways that spur cancer growth, resulting in the regression of KS tumors within 4 weeks in some patients. The study will be published November 30 in the Journal of Clinical Oncology (JCO).

30 Nov 2004

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

A new study published in the New England Journal of Medicine confirms that stem cells derived from the umbilical cords of newborn babies are a viable and effective transplant source for thousands of leukemia patients who have no other treatment option.

24 Nov 2004

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Scientists from Glasgow and Liverpool are joining forces to improve the effectiveness of a drug used to treat a form of leukaemia, chronic myeloid leukaemia (CML), which affects 750 people in the UK each year.

24 Nov 2004

Chernobyl disaster caused cancer cases in Sweden

A statistically determined correlation between radioactive fallout from the Chernobyl accident and an increase in the number of cases of cancer in the exposed areas in Sweden is reported in a study by scientists at Linköping University, Örebro University, and the County Council of Västernorrland County.

19 Nov 2004

U.S. nuclear power workers show no unexepected radiation related cancer

A first-of-its-kind study of more than 53,000 U.S. nuclear power workers has found that employees in the commercial nuclear industry are less likely than the general population to die from cancer or non-cancer diseases due, in large measure, to the so-called "healthy worker effect."

18 Nov 2004

Animal research and its benefits to both humans and animals

From preventing polio to finding cures for cancer patients, animal research has saved countless lives.

18 Nov 2004

Understanding the signals that delay the spread of follicular lymphoma could provide new therapeutic targets

Scientists at the National Cancer Institute (NCI), have created a model that predicts the survival of follicular lymphoma patients based on the molecular characteristics of their tumors at diagnosis.

18 Nov 2004

36% of cancer patients ages 65 and older participate in clinical trials

A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).

14 Nov 2004

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc., has been allowed a patent by the Canadian Patent Office entitled "Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase."

10 Nov 2004

Cranberry juice may help prevent gum disease

New research presented at a recent symposium suggests that cranberry juice may help prevent certain oral health problems, including diseases of the gums and teeth.

9 Nov 2004

Impaired cognitive and motor function following stem cell transplantation for severe blood disorders can improve

Patients who suffer a loss of cognitive and motor function as a result of stem cell transplantation for severe blood disorders are likely to see those functions return to previous levels after one year, according to a new study in the November 15, 2004, issue of Blood, the official journal of the American Society of Hematology.

8 Nov 2004

Researchers have documented a novel form of resistance in leukemia cells to an anti-cancer drug

Researchers at Virginia Commonwealth University’s Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.

8 Nov 2004

Obesity could more than double an older woman's risk of acute myelogenous leukemia

A study from the University of Minnesota Cancer Center indicates that overweight and obesity could more than double an older woman's risk of acute myelogenous leukemia (AML), an often fatal cancer of the bone marrow and blood.

8 Nov 2004

Cellular vehicle delivers drugs directly into cancer cells

Researchers at The University of Texas M. D. Anderson Cancer Center have perfected a delivery system for anticancer treatment that zeroes in on a tumor and becomes part of its supporting tissue.

4 Nov 2004

Some allergic conditions could increase your risk of suffering from blood cancer

Some allergic conditions could increase your risk of suffering from blood cancer as an adult, according to a new study published in the November 2004 issue of BMC Public Health. This is important news for the increasingly large numbers of allergy sufferers worldwide.

4 Nov 2004

Peripheral blood transplants from donors may be more harmful than bone marrow transplants in pediatric leukemia patients

A new study has shown for the first time that transplantation of peripheral blood stem cells (PBSC) from sibling donors may be more harmful than bone marrow in pediatric leukemia patients.

3 Nov 2004

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Maxim Pharmaceuticals has announced that based upon the negative outcome of it's confirmatory Phase 3 clinical trial (M0104) studying Ceplene(TM) (histamine dihydrochloride) in combination with Interleukin-2 (IL-2) in advanced malignant melanoma patients with liver metastases, it plans to close the treatment protocol approved by the FDA earlier this year.

2 Nov 2004

Improved risk classification for patients with acute lymphoblastic leukemia offers hope for eliminating irradiation

Improved risk classification for patients with acute lymphoblastic leukemia (ALL), coupled with more intensive intrathecal chemotherapy for high risk patients and the use of a drug called dexamethasone, could one day permit physicians to omit irradiation as a part of routine treatment.

1 Nov 2004

Gene silencing may provide hope for leukemia sufferers

Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.

1 Nov 2004

Micro-array technology is revolutionising current drug development

Gene expression micro-array technology is benefiting all phases of the discovery, development and subsequent use of new cancer therapeutics

29 Oct 2004

Leukemia News and Research

Further Reading

Imatinib mesylate (Gleevec) inhibits important pathways that spur cancer growth

Stem cells derived from umbilical cords are a viable and effective transplant source for thousands of leukemia patients

Scientists join forces to improve the effectiveness of a drug used to treat chronic myeloid leukaemia

Chernobyl disaster caused cancer cases in Sweden

U.S. nuclear power workers show no unexepected radiation related cancer

Animal research and its benefits to both humans and animals

Understanding the signals that delay the spread of follicular lymphoma could provide new therapeutic targets

36% of cancer patients ages 65 and older participate in clinical trials

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Cranberry juice may help prevent gum disease

Impaired cognitive and motor function following stem cell transplantation for severe blood disorders can improve

Researchers have documented a novel form of resistance in leukemia cells to an anti-cancer drug

Obesity could more than double an older woman's risk of acute myelogenous leukemia

Cellular vehicle delivers drugs directly into cancer cells

Some allergic conditions could increase your risk of suffering from blood cancer

Peripheral blood transplants from donors may be more harmful than bone marrow transplants in pediatric leukemia patients

Maxim Pharmaceuticals to withdraw NDA for advanced malignant melanoma

Improved risk classification for patients with acute lymphoblastic leukemia offers hope for eliminating irradiation

Gene silencing may provide hope for leukemia sufferers

Micro-array technology is revolutionising current drug development

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News